Missed NVDA?
Don’t Miss the Next One.
Join 5,000+ investors using Ticker Nerd’s Market Radar to stay ahead of major market moves, analyst upgrades, and trending opportunities — for free.
ZEPP Stock Forecast 2026-2027
$20.59
Current Price
$301.13M
Market Cap
Buy 1
Hold 0
Sell 0
Wall St Analyst Ratings
Distance to ZEPP Price Targets
+212.6%
To High Target of $64.37
+212.6%
To Median Target of $64.37
+212.6%
To Low Target of $64.37
ZEPP Price Momentum
+13.9%
1 Week Change
-11.7%
1 Month Change
+588.6%
1 Year Change
-23.6%
Year-to-Date Change
-66.7%
From 52W High of $61.85
+868.9%
From 52W Low of $2.13
📊 TOP ANALYST CALLS
Did ZEPP Make This Month's Elite Buy List?
We don't follow just any analyst — only the top 3% with a proven track record make our cut. See if Zepp Health is one of their latest high-conviction picks.
Latest ZEPP Stock Price Targets & Analyst Predictions
Wall Street analysts covering ZEPP have a bullish consensus with a median price target of $64.37 (ranging from $64.37 to $64.37). The overall analyst rating is N/A (N/A/10). Currently trading at $20.59, the median forecast implies a 212.6% upside. This outlook is supported by 1 Buy, 0 Hold, and 0 Sell ratings.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
ZEPP Analyst Ratings
1
Buy
0
Hold
0
Sell
ZEPP Price Target Range
Low
$64.37
Average
$64.37
High
$64.37
Current: $20.59
Latest ZEPP Stock Forecasts by Analyst
These are the latest 20 analyst ratings and price targets for ZEPP.
| Date | Firm | Analyst | Rating | Change | Price Target |
|---|
Zepp Health Corp. Depositary Receipt (ZEPP) Competitors
The following stocks are similar to Zepp Health based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
ZEPP
Zepp Health
mkt cap
264.42M
Zepp Health Corp. Depositary Receipt (ZEPP) Financial Data
Zepp Health Corp. Depositary Receipt has a market capitalization of $301.13M with a P/E ratio of -4.5x. The company generates $233.27M in trailing twelve-month revenue with a -28.3% profit margin.
Revenue growth is +78.5% quarter-over-quarter, while maintaining an operating margin of -1.2% and return on equity of -24.4%.
Valuation Metrics
Market Cap
$301.13M
Enterprise Value
$5.26B
P/E Ratio
-4.5x
PEG Ratio
0.1x
Price/Sales
1.3x
Growth & Margins
Revenue Growth (YoY)
+78.5%
Gross Margin
+38.2%
Operating Margin
-1.2%
Net Margin
-28.3%
EPS Growth
+78.5%
Financial Health
Cash/Price Ratio
+1.2%
Current Ratio
1.1x
Debt/Equity
48.7x
ROE
-24.4%
ROA
-3.6%
💡 SKIP THE NOISE
97% of Analyst Ratings Go Nowhere
We filter thousands of calls to find the few that actually matter. Get the top analyst buy ratings — tracked and updated every Monday and Thursday.
Zepp Health Corp. Depositary Receipt (ZEPP) Business Model
About Zepp Health Corp. Depositary Receipt
What They Do
Develops smart wearable and health technology.
Business Model
Zepp Health Corporation generates revenue by designing, manufacturing, and selling a variety of smart health devices, including smartwatches and fitness bands. The depositary receipts allow international investors to access the company's shares, facilitating broader investment opportunities in the growing wearable technology market.
Additional Information
Founded in 2013 and formerly known as Huami Corporation, Zepp Health has shipped over 200 million devices globally and caters to users in more than 90 countries. The company is recognized for its innovative brands such as Amazfit and Zepp, positioning itself at the convergence of consumer electronics and healthcare.
Company Information
Sector
Technology
Industry
Consumer Electronics
Employees
765
CEO
Mr. Wang Huang
Country
Netherlands
IPO Year
2018
Website
www.huami.comZepp Health Corp. Depositary Receipt (ZEPP) Latest News & Analysis
Latest News
Quick Summary
An earnings call is scheduled for March 15, 2026, at 9:30 p.m. ET, according to a company based in Milpitas, California.
Why It Matters
The scheduled earnings call indicates upcoming financial performance insights, impacting stock valuation and investor sentiment.
Source: PRNewsWire
Market Sentiment:
Neutral
Quick Summary
Amazfit, owned by Zepp Health, launched the Active 3 Premium smartwatch, targeting athletes with features for structured running and hybrid training.
Why It Matters
Amazfit's launch of the Active 3 Premium smartwatch targets athletes, expanding its product line and potentially increasing market share in the competitive wearables industry, impacting Zepp Health's growth prospects.
Source: Business Wire
Market Sentiment:
Neutral
Quick Summary
Amazfit, owned by Zepp Health, launched the T-Rex Ultra 2, a rugged smartwatch designed for extreme conditions, featuring premium materials and enhanced navigation capabilities.
Why It Matters
The launch of the T-Rex Ultra 2 indicates Zepp Health's commitment to innovation in the competitive wearables market, potentially driving sales and enhancing market share, which could positively impact stock performance.
Source: Business Wire
Market Sentiment:
Neutral
Quick Summary
Zepp Health gets a buy rating with a $21.2 price target, suggesting 22% upside. Q3 revenue grew 78.5% YoY, aided by Amazfit products and operational efficiencies.
Why It Matters
Zepp Health's buy rating and strong revenue growth indicate bullish sentiment, while improving profitability and a share repurchase program suggest potential for further stock appreciation.
Source: Seeking Alpha
Market Sentiment:
Positive
Quick Summary
Amazfit will showcase its vision for the future of sports technology at CES 2026 in Las Vegas, highlighting its commitment to innovation in the sports tech sector.
Why It Matters
Amazfit's presence at CES 2026 signals innovation in sports tech, potentially boosting market interest and impacting stock prices of related companies.
Source: Business Wire
Market Sentiment:
Neutral
Quick Summary
Amazfit, by Zepp Health (NYSE: ZEPP), launched the Amazfit Active Max, featuring a 1.5" AMOLED display, 25-day battery life, and advanced training tools for athletes and wellness enthusiasts.
Why It Matters
The launch of Amazfit Active Max could drive sales growth for Zepp Health, potentially enhancing revenue and market share in the competitive wearable tech sector, influencing stock performance.
Source: Business Wire
Market Sentiment:
Neutral
Frequently Asked Questions About ZEPP Stock
What is Zepp Health Corp. Depositary Receipt's (ZEPP) stock forecast for 2026?
Based on our analysis of 0 Wall Street analysts, Zepp Health Corp. Depositary Receipt (ZEPP) has a median price target of $64.37. The highest price target is $64.37 and the lowest is $64.37.
Is ZEPP stock a good investment in 2026?
According to current analyst ratings, ZEPP has 1 Buy ratings, 0 Hold ratings, and 0 Sell ratings. The stock is currently trading at $20.59. Always conduct your own research and consider your investment goals before making investment decisions.
What is the long-term price prediction for ZEPP stock?
Wall Street analysts predict ZEPP stock could reach $64.37 in the next 12 months. This represents a 212.6% increase from the current price of $20.59. Please note that this is a projection by Wall Street analysts and not a guarantee.
What is Zepp Health Corp. Depositary Receipt's business model?
Zepp Health Corporation generates revenue by designing, manufacturing, and selling a variety of smart health devices, including smartwatches and fitness bands. The depositary receipts allow international investors to access the company's shares, facilitating broader investment opportunities in the growing wearable technology market.
What is the highest forecasted price for ZEPP Zepp Health Corp. Depositary Receipt?
The highest price target for ZEPP is $64.37 from at , which represents a 212.6% increase from the current price of $20.59.
What is the lowest forecasted price for ZEPP Zepp Health Corp. Depositary Receipt?
The lowest price target for ZEPP is $64.37 from at , which represents a 212.6% increase from the current price of $20.59.
What is the overall ZEPP consensus from analysts for Zepp Health Corp. Depositary Receipt?
The overall analyst consensus for ZEPP is bullish. Out of 0 Wall Street analysts, 1 rate it as Buy, 0 as Hold, and 0 as Sell, with a median price target of $64.37.
How accurate are ZEPP stock price projections?
Stock price projections, including those for Zepp Health Corp. Depositary Receipt, are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.
Important Disclaimer
The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.
Last updated: March 13, 2026 7:37 PM UTC